MedTrace Logo

Multimodal Gait Training With and Without Rhythmic Auditory Stimulation in Chronic Stroke Patients

NCT06696950 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2024-11-20

No results posted yet for this study

Summary

The primary goal of this randomized clinical trial is to investigate the efficacy of multimodal gait training, with and without rhythmic auditory stimulation, in improving gait, coordination and reducing fall risk in individuals with chronic stroke This clinical trial features two distinct groups 42 participants were randomly divided into two groups of 21. Group A will receive Multimodal gait training along with rhythmic auditory stimulation while Group B will receive only multimodal gait training

Participants will:

* Take 12 sessions of the MMGT program over six weeks
* With each session lasting 45 minutes, including 10-minute rest breaks.

Conditions

  • Chronic Stroke Patients

Interventions

OTHER

Mutimodal gait training includes unilateral step training, inclined treadmill training, over ground training with rhythmic auditory stimulation

Unilateral step training, inclined treadmill training, over ground training, repetitive isochronous pulses via metronome

OTHER

Multimodal gait training

Unilateral step training, inclined treadmill training, over ground training,

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Binish Afzal, MS-NMPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-10
Primary Completion
2024-11-30
Completion
2024-12-05

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06696950 on ClinicalTrials.gov